DAEWOONG CO.,LTD Logo

DAEWOONG CO.,LTD

003090 | KO

Overview

Corporate Details

ISIN(s):
KR7003090008
LEI:
Country:
South Korea
Address:
경기 성남시 중원구 상대원동 223-23, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 14.9 KB
2025-09-05 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.0 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 3.7 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.0 MB
2025-07-30 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.5 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 708.5 KB
2025-05-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 162.0 KB
2025-05-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 58.0 KB
2025-05-15 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 54.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-14 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 60.7 KB
2025-04-16 00:00
Capital/Financing Update
단기차입금증가결정(자회사의 주요경영사항)
Korean 11.5 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 62.4 KB

Automate Your Workflow. Get a real-time feed of all DAEWOONG CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DAEWOONG CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DAEWOONG CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.